Cue Biopharma
Develops immune-modulating biologics for autoimmune and allergic diseases.
$27.88
After-hours close−0.30 (−1.06%)
At close$28.18(+0.07%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.35 | — | — |
| Aug 2026 | −$1.69 | −$24.14 | −1,328.4% |
| May 2026 | −$3.30 | −$1.08 | +67.3% |
| Mar 2026 | −$2.70 | $0.30 | +111.1% |
| Nov 2025 | −$0.10 | −$0.07 | +30.0% |
The latest year is open to everyone — the 38 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$1.35 | — | — | $1.6M | — | — |
| Aug 14, 2026 | −$1.69 | −$24.14 | −1,328.4% | $3.0M | $7.9M | +162.6% |
| May 14, 2026 | −$3.30 | −$1.08 | +67.3% | $2.5M | $5.7M | +127.4% |
| Mar 16, 2026 | −$2.70 | $0.30 | +111.1% | $1.0M | $21.9M | +2,094.2% |
| Nov 12, 2025 | −$0.10 | −$0.07 | +30.0% | $2.3M | $2.1M | −6.1% |
The latest year is open to everyone — the 38 quarters behind it read with an account. Sign in | ||||||
| Aug 12, 2025 | ||||||
| May 12, 2025 | ||||||
| Mar 31, 2025 | ||||||
| Nov 14, 2024 | ||||||
| Aug 19, 2024 | ||||||
| May 9, 2024 | ||||||
| Apr 8, 2024 | ||||||
| Nov 9, 2023 | ||||||
| Aug 9, 2023 | ||||||
| May 9, 2023 | ||||||
| Mar 21, 2023 | ||||||
| Nov 14, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 10, 2022 | ||||||
| Mar 16, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 9, 2021 | ||||||
| May 17, 2021 | ||||||
| Mar 16, 2021 | ||||||
| Nov 17, 2020 | ||||||
| Aug 7, 2020 | ||||||
| May 7, 2020 | ||||||
| Mar 12, 2020 | ||||||
| Nov 7, 2019 | ||||||
| Aug 8, 2019 | ||||||
| May 8, 2019 | ||||||
| Mar 14, 2019 | ||||||
| Nov 13, 2018 | ||||||
| Aug 13, 2018 | ||||||
| May 14, 2018 | ||||||
| Mar 29, 2018 | ||||||
| Sep 30, 2017 | ||||||
| Jun 30, 2017 | ||||||
| Mar 31, 2017 | ||||||
| Dec 31, 2016 | ||||||
| Sep 30, 2016 | ||||||
| Jun 30, 2016 | ||||||
| Mar 31, 2016 | ||||||